What is Ovagen?
Ovagen is a purified follicle-stimulating hormone (FSH) preparation derived from pituitary glands. FSH is a hormone that plays a key role in reproduction — it signals the ovaries to develop and release eggs. In the research world, Ovagen is classified as a bioregulator: a compound that works with the body's own biological systems rather than overriding them. It has been studied primarily in animal reproductive biology, with researchers examining how it influences ovulation, embryo development, and related processes.
Important note: Ovagen is a research compound. Nothing on this page is medical advice, and this compound is not approved for human therapeutic use.
How Ovagen Works
Think of FSH as a "starter signal" for the ovaries. When FSH arrives, follicles — the tiny fluid-filled sacs that house developing eggs — begin to grow and mature. Ovagen delivers that signal in a concentrated, measurable form.
One thing that makes Ovagen stand out among FSH preparations is its unusually high FSH-to-LH ratio. LH (luteinizing hormone) is a related hormone that can interfere with results if present in large amounts. Researchers found that Ovagen's FSH-to-LH ratio was approximately 1090 — far higher than other common preparations like Folligon (ratio of 5) or FSH-P (ratio of 18).[2] That high purity makes it a useful research tool when scientists want to study FSH effects in isolation.
Once injected into the bloodstream, Ovagen has a measured half-life of about 13.4 minutes in mice — meaning it clears from the blood relatively quickly. Studies also showed that Ovagen's biological potency in lab assays was about 25–50% that of a standard reference FSH preparation, and its behavior varied across different assay types, which is important context when interpreting research results.[6]
What the Research Shows
Most published research on Ovagen comes from veterinary and reproductive science, where it has been used to trigger superovulation (producing many eggs at once) and improve embryo collection in livestock.
- Goats: In an early New Zealand study, goats treated with Ovagen produced an average of 16.2 corpora lutea (ovulation sites) and 12.6 recovered embryos, with 11.1 of those rated as good-quality and transferable. There were no significant differences compared to another FSH product (Folltropin), but notably, no abnormal or prematurely regressing ovulation sites were found in the Ovagen group, while 22% of the Folltropin group showed such abnormalities.[1]
- Goats (single vs. multiple injections): A later study compared Ovagen given as eight injections (the standard protocol) against single-injection approaches combined with other hormones. The multi-injection Ovagen control performed competitively, and results helped researchers understand how dosing frequency affects embryo yield.[3]
- Immature rats: Researchers tested how well Ovagen triggered oocyte (egg) production in young rats. Unlike some other preparations, Ovagen only produced results when delivered by continuous infusion rather than a single injection. At its best, Ovagen produced an average of 47 oocytes — comparable to the top performer in the study.[2]
- Dairy cattle in the tropics: Ovagen was compared to another product (SUPER-OV) in dairy cows in a tropical setting. Both produced similar numbers of ovulation sites (around 7.6–7.9 palpable corpora lutea). Cows treated with Ovagen tended to yield a higher total number and proportion of viable, transferable embryos, though differences were not always statistically significant.[5]
- Ewes (cervical relaxation): In a creative application, researchers administered Ovagen directly into the cervix of ewes to see if it could relax the cervical canal — making it easier to pass an insemination pipette through. When given 24 hours after progesterone sponge removal, a 2 mg intra-cervical dose allowed 100% of ewes to be successfully penetrated at 54 and 60 hours after sponge removal. FSH appeared to be biologically active even when applied topically this way.[4]
What Ovagen Is Being Studied For
- Superovulation protocols in research animals (goats, cattle, sheep, rats)
- Embryo collection and transfer programs in livestock research
- Follicular development and turnover studies in cattle
- Cervical relaxation to facilitate reproductive procedures in ewes
- Comparative FSH bioactivity and pharmacokinetics research[6]
How Ovagen Is Dosed in Research
Dosing in published studies varies widely depending on the species, the goal of the experiment, and whether single or multiple administrations are used. For example, studies in rats used continuous infusion protocols, while goat and cattle studies relied on multiple timed injections spread across days. Ewe cervical relaxation research used a single local application. Because the dosing protocols are highly specific to each research context, we've compiled all the figures from published trials in the dosage chart on this page. You can also use the calculator to work through preparation math for your specific research setup.
Mixing and Storing Ovagen
Ovagen, like most peptide-based FSH preparations, is supplied as a lyophilized (freeze-dried) powder. To reconstitute it for research use, sterile bacteriostatic water or sterile saline is typically used. Add the diluent slowly to the vial, then gently swirl — never shake vigorously, as this can damage the protein structure. Once reconstituted, the solution should be stored at 2–8°C (standard refrigerator temperature) and used within the timeframe recommended by your supplier. For long-term storage before reconstitution, keep the dry powder frozen and away from light. Always handle using sterile technique to avoid contamination.
Sources
- Superovulation and embryo recovery in goats treated with Ovagen and Folltropin. — New Zealand veterinary journal, 1989. PMID 16031503.
- Oocyte production and ovarian steroid concentrations of immature rats in response to some commercial gonadotrophin preparations. — Reproduction, fertility, and development, 1990. PMID 2128901.
- Use of single or multiple injections of FSH in embryo collection programmes in goats. — Reproduction, fertility, and development, 1993. PMID 8234893.
- The effects of the prostaglandin E analogue Misoprostol and follicle-stimulating hormone on cervical penetrability in ewes during the peri-ovulatory period. — Theriogenology, 2007. PMID 17126896.
- Superovulatory response of dairy cattle (Bos taurus ) in a tropical environment. — Theriogenology, 1997. PMID 16728100.
- Biopotency in vitro and metabolic clearance rates of five pituitary preparations of follicle stimulating hormone. — Reproduction, fertility, and development, 1993. PMID 8265802.
EN
BR
ES
FR